Two Sigma Advisers
CRVO icon

Two Sigma Advisers’s CervoMed CRVO Stock Holding History

Two Sigma Advisers’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,200
Closed -$41K – 2697
2022
Q1 		$41K Sell
2,200
-787
-26% -$15.6K ﹤0.01% 2610
2021
Q4 		$68K Buy
+2,987
New +$93.4K ﹤0.01% 2452
2021
Q2 		– Sell
-649
Closed -$45K – 2489
2021
Q1 		$45K Sell
649
-280
-30% -$23.5K ﹤0.01% 2502
2020
Q4 		$55K Buy
+929
New +$54.4K ﹤0.01% 2310
2020
Q2 		– Sell
-172
Closed -$4K – 2507
2020
Q1 		$4K Buy
+172
New +$5.22K ﹤0.01% 2438

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Advisers's CRVO Position: Q2 2022 in Review

Two Sigma Advisers sold out of CervoMed (CRVO) in Q2 2022, closing a stake of 2,200 shares — an estimated $41K sold.

Two Sigma Advisers first reported a position in CRVO in Q1 2020 and held it in 5 quarters. The position peaked at $68K in Q4 2021. 15 funds tracked by Wall St. Rank hold CRVO as of Q2 2022.

  • Two Sigma Advisers reported no remaining CervoMed position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 2,200 CervoMed shares in Q2 2022, an estimated $41K.
  • Two Sigma Advisers first reported a position in CervoMed in Q1 2020 and held it in 5 quarters.
  • Two Sigma Advisers's CervoMed position peaked at $68K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held CervoMed as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.